20 medical device startups you need to know

April 13, 2018 By Chris Newmarker

[Image courtesy of Metavention]

Metavention

Minneapolis

Founded: 2012

www.metavention.com

Metavention in January closed a $65 million Series C round, with funding from New Enterprise Associates, Sanderling Ventures and others. The money is going toward optimizing Metavention’s transcatheter-based metabolic neuromodulation therapy for people with Type II diabetes. The company at the time said it was preparing for a Phase II trial in the U.S.

The goal is to “provide improved control of elevated glucose, in a single minimally invasive procedure,” according to CEO Todd Berg.

–Chris Newmarker, Managing Editor

Next >>

And vote in our survey>>

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.